ReviewDrug design, development and therapy2015

Profile of paritaprevir/ritonavir/ombitasvir plus dasabuvir in the treatment of chronic hepatitis C virus genotype 1 infection.

Michael A Smith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.